Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

DP1 Receptor Polyclonal Antibody

  • Zoom
    DP<sub>1</sub> Receptor Polyclonal Antibody
  • DP<sub>1</sub> Receptor Polyclonal Antibody
Cat No: 101640
Cayman

Prostaglandin D2 (PGD2) binds to two receptor subtypes: DP1 and CRTH2/DP2, which are both membrane-bound G protein-coupled receptors (GPCRs) but do not have significant homology and are differentially expressed.{63189} The DP1 receptor is expressed in...

More
: 1 ea

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Correlated keywords:
  • PGD-2 DP-1 CRTH-2
Product Overview:
Prostaglandin D2 (PGD2) binds to two receptor subtypes: DP1 and CRTH2/DP2, which are both membrane-bound G protein-coupled receptors (GPCRs) but do not have significant homology and are differentially expressed.{63189} The DP1 receptor is expressed in various tissues and cells including the brain, spleen, lungs, bone marrow, stomach, skin, and mast cells.{3175,3128,9114} It is coupled to Gαs, and its activation increases intracellular cAMP levels.{11488} Signaling through the DP1 receptor is involved in inflammation, allergy, and sleep regulation.{11488,63189} Cayman’s DP1 Receptor Polyclonal Antibody can be used for immunofluorescence (IF) and Western blot (WB) applications. The antibody recognizes the DP1 receptor at approximately 41 kDa from human, mouse, and rat samples.
Size 1 ea
Shipping dry ice
Host Rabbit
Antigen Peptide from the N-terminal region of mouse DP1 receptor
Application(s)

IF, WB

Formulation 500 µl of peptide-affinity purified antibody
Custom Code 3822.19
UNSPSC code 12352203

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : DP<sub>1</sub> Receptor Polyclonal Antibody There are 10 products.

Search